Rhopressa netarsudil fda approval date?

When did Rhopressa (netarsudil ophthalmic solution) get FDA approval?

Rhopressa (netarsudil ophthalmic solution) received FDA approval on December 18, 2017. [1]

What drug is Rhopressa and what is it used for?

Rhopressa is an eye drop (netarsudil) approved for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. [1]

Where can I verify the approval date?

You can cross-check the approval timeline on DrugPatentWatch.com. [1]

Sources
[1] https://www.drugpatentwatch.com/